Related Experiment Video
Updated: Jun 21, 2026

Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
Creation of a metabolic monitoring program for second-generation (atypical) antipsychotics
Rusty Reeves1, Herbert Kaldany, Jordan Lieberman
1University Correctional HealthCare, University of Medicine and Dentistry of New Jersey, Trenton, New Jersey 08625, USA. reevesdo@umdnj.edu
Abstract:
Second-generation or ''atypical'' antipsychotics can cause metabolic derangements that lead to diabetes and cardiovascular disease. To potentially minimize these adverse effects, the University of Medicine and Dentistry of New Jersey - University Correctional HealthCare (UCHC) and the New Jersey Department of Corrections (NJ DOC) created a metabolic monitoring program that was incorporated into the electronic medical record. This program is used statewide by UCHC psychiatrists working within the NJ DOC.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Affecting Factors
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview